-
Friday, January 25, 2013 - 5:02pm
Nassim Taleb Likes Steve Jobs, Not Apple
Nassim Taleb, author of The Black Swan, isn't a fan of Apple (NASDAQ: AAPL). In his most recent book, Antifragile, Taleb makes numerous references to the Apple products he owns and draws on the wisdom of the late Steve Jobs to help support some of his arguments. But despite his high opinion of...
Read More >>
Antifragile
Benzinga Professional
- 10:38 AM UPDATE: Morgan Stanley Maintains Overweight on Monster Beverage Despite Recent Sales Slowdown
- 10:32 AM Benzinga's Volume Movers
- 10:25 AM AllThingsD Reporting AOL Has Considered 'Bling Thing,' 'a New Subscription Commerce Business'
- 10:23 AM Stocks Hitting 52-Week Lows
- 10:23 AM JP Morgan Maintains Overweight on Boeing Company (The), Raises PT to $105.00
- 10:23 AM Maxim Group Maintains Buy on Qihoo 360 Technology Co. Ltd., Raises PT to $48.00
- 10:22 AM Stocks Hitting 52-Week Highs
- 10:22 AM Goldman Sachs Downgrades Neustar, Inc. to Neutral
- 10:22 AM Goldman Sachs Downgrades Equifax, Inc. to Neutral
- 10:22 AM Goldman Sachs Upgrades WNS (Holdings) Limited to Buy, Raises to $19.00
- 10:21 AM Goldman Sachs Upgrades Accenture plc. to Buy, Raises to $90.00
- 10:20 AM Piper Jaffray Maintains Neutral on Hibbett Sports, Inc., Raises PT to $62.00
- 10:20 AM Piper Jaffray Maintains Overweight on Monsanto Company, Raises PT to $135.00
- 10:20 AM US Dollar Has First Down Day Since May 8; Christopher Vecchio, Currency Analyst at DailyFX, comments on the US Dollar and the Japanese Yen
- 10:19 AM Piper Jaffray Maintains Overweight on American Vanguard Corporation, Raises PT to $37.00
Brain Trust
MORE FROM InvestorsObserver
MORE FROM Michael Prus
- Yahoo Jumping on the Startup Acquisition Bandwagon
- UPDATE: Morgan Stanley Maintains Overweight on Monster Beverage Despite Recent Sales Slowdown
- Natus Medical Reports Strong Q1 Earnings
- Campbell's Reports Strong Q3 Earnings
- Qihoo Shares Rise on Q1 Earnings
- Benzinga's Volume Movers
- Technical Forecast for Aluminium for 19th May 2013
- JA Solar Rises to Two-Year High on Bright First Quarter
- Stocks Hitting 52-Week Lows
- Stocks Hitting 52-Week Highs
- The 5 Can't-Miss Apple Stories from the Past Week
- Earnings Expectations for the Week of May 20
- U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying
- Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung Cancer
- Barron's Recap: Cues from Cooperman
- Benzinga's M&A Chatter for Friday May 17, 2013
- Campbell Soup Earnings Preview: Double-Digit Revenue Growth Expected
- Can You Think of 9 Companies with Stellar Customer Service?
- Benzinga Market Primer: Monday, May 20
- Presidential Visit Puts Myanmar Investment Theme in Spotlight